CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
4.96
-1.07 (-17.74%)
At close: Aug 15, 2025, 3:59 PM
5.43
9.48%
After-hours: Aug 15, 2025, 07:47 PM EDT
CNS Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.61M | -14.86M | -17.06M | -15.97M | -17.46M | -18.85M | -18.98M | -17.88M | -17.42M | -15.64M | -12.93M | -13.33M | -13.57M | -14.04M | -14.25M | -12.44M | -11.1M |
Depreciation & Amortization | 3.59K | 3.31K | 3.27K | 3.42K | 3.67K | 4.13K | 5.56K | 7.46K | 9.66K | 11.76K | 12.87K | 13.44K | 13.45K | 13.07K | 12.72K | 12.52K | 12.18K |
Stock-Based Compensation | 698.39K | 838.96K | 941.73K | 864.71K | 920.04K | 1.01M | 1.06M | 1.16M | 1.16M | 1.2M | 1.23M | 1.45M | 1.63M | 1.72M | 1.77M | 1.63M | 1.48M |
Other Working Capital | -1.58M | -2.47M | 2.56M | 4.3M | 3.2M | 3.81M | 1.56M | 1.41M | 1.78M | 1.46M | 286.58K | 227.36K | -1.18M | -1.68M | -364.88K | -835.07K | 102.75K |
Other Non-Cash Items | -672.19K | -672.38K | -672.64K | 308.00 | -498.05K | 696.31K | 1.03M | 1.03M | 1.53M | 337.25K | 838K | 836.83K | 835.37K | 835.37K | 835.37K | 835.37K | 835.37K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 498.36K | -695.81K | -695.81K | -695.81K | -1.19M | n/a | -835.37K | -835.37K | -835.37K | -835.37K | -833.78K | -833.78K | -833.78K |
Change in Working Capital | -1.58M | -2.43M | 2.61M | 4.35M | 4.03M | 3.7M | 3.67M | 4.03M | 3.61M | 3.53M | 197.49K | 193.19K | -1.38M | -1.24M | 713.86K | -225.74K | 836.54K |
Operating Cash Flow | -17.16M | -17.11M | -14.18M | -10.76M | -12.51M | -14.14M | -13.91M | -12.35M | -12.31M | -10.56M | -11.49M | -11.67M | -13.31M | -13.54M | -11.75M | -11.03M | -8.77M |
Capital Expenditures | -4.19K | -4.19K | -2.16K | -3.9K | -3.9K | -3.9K | -1.74K | -1.51K | -4.42K | -4.42K | -6.5K | -4.99K | -2.08K | -5.75K | -3.67K | -3.67K | -15.21K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -4.19K | -4.19K | -2.16K | -3.9K | -3.9K | -3.9K | -1.74K | -1.51K | -4.42K | -4.42K | -6.5K | -4.99K | -2.08K | -5.75K | -3.67K | -3.67K | -15.21K |
Debt Repayment | -299.99K | -300.81K | -340.29K | -372.72K | -405.54K | -438.73K | -447.23K | -439.88K | -433.37K | -427.7K | -431.36K | -447.18K | -462.55K | -477.49K | -437.74K | -304.79K | -173.24K |
Common Stock Repurchased | -557 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 824.71K | -45.42K | 2M | 2.04M | 2.05M | 2.03M | 118.00 | 118.00 | 118.00 | 2.73K | 2.62K | 2.62K | 2.62K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 29.4M | 23.03M | 20.24M | 7.97M | 8.22M | 4.64M | 7.79M | 7.67M | 4.98M | 15.61M | 10.2M | 13.75M | 14.67M | 4.51M | 18.77M | 15.29M | 14.48M |
Net Cash Flow | 12.23M | 5.91M | 6.06M | -2.79M | -4.3M | -9.51M | -6.12M | -4.68M | -7.33M | 5.05M | -1.3M | 2.07M | 1.37M | -9.03M | 7.02M | 4.26M | 5.7M |
Free Cash Flow | -17.17M | -17.12M | -14.18M | -10.76M | -12.51M | -14.14M | -13.91M | -12.35M | -12.31M | -10.56M | -11.5M | -11.68M | -13.31M | -13.54M | -11.75M | -11.03M | -8.79M |